James Ahlers

James Ahlers

Financieel Directeur/CFO bij CUE BIOPHARMA, INC.

Vermogen: 650 760 $ op 31-08-2026

61 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Mr. James M.
Ahlers
is a Chief Financial Officer at Cue Biopharma, Inc. Mr. Ahlers was previously employed as an Executive Vice President-Corporate Finance by Intensity Therapeutics, Inc., a Chief Financial Officer by RenovoRx, Inc., a Chief Financial Officer by Intarcia Therapeutics, Inc., a Director-Finance & Administration by Ansan Pharmaceuticals, Inc., a Financial Consultant by Cytokinetics, Inc., a Member-Audit Department by Deloitte & Touche LLP, a Financial Consultant by Genesoft Pharmaceuticals, Inc., a Manager-Financial Planning & Analysis by Medco Behavioral Care Corp., a Director-Finance & Administration by Titan Pharmaceuticals, Inc., and a Financial Consultant by Tularik, Inc. He received his undergraduate degree from the University of San Francisco.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
30-07-2026 25.500 ( 0,35% ) 650 760 $ 31-08-2026

Actieve functies van James Ahlers

BedrijvenFunctieBegin
CUE BIOPHARMA, INC. Financieel Directeur/CFO 30-07-2026

Eerdere bekende functies van James Ahlers

BedrijvenFunctieEinde
INTENSITY THERAPEUTICS, INC. Corporate Officer/Principal 21-05-2024
RENOVORX, INC. Financieel Directeur/CFO 05-02-2024
Financieel Directeur/CFO 01-11-2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van James Ahlers in detail bekijken

Opleiding van James Ahlers

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. James Ahlers